Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Clinical proteomics: Insights from IGF-I

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reference values for leptin/adiponectin ratio in healthy children and adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Validation of image cytometry for sperm concentration measurement: Comparison with manual counting of 4010 human semen samples

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Longitudinal Increases in Serum Insulin-like Factor 3 and Testosterone Determined by LC-MS/MS in Pubertal Danish Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Marked Increase in Incident Gynecomastia: A 20-Year National Registry Study, 1998 to 2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Grouping of endocrine disrupting chemicals for mixture risk assessment - Evidence from a rat study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Clinical proteomics aims to deliver cost-effective multiplexing of potentially hundreds of diagnostic proteins, including distinct protein isoforms. The analytical strategy known as targeted proteomics is particularly promising because it is compatible with robust mass spectrometry (MS)-platforms already implemented in many clinical laboratories for routine quantitation of small molecules (i.e. uHPLC coupled to triple-quadrupole MS). Progress in targeted proteomics of circulating insulin-like growth factor 1 (IGF-I) have provided valuable insights about tryptic peptides, transitions, internal standards and calibrants. The present challenge is to examine if targeted proteomics of IGF-I can truly measure up to the routine performance that must be expected from a clinical testing platform.

OriginalsprogEngelsk
TidsskriftClinica chimica acta; international journal of clinical chemistry
Vol/bind477
Sider (fra-til)18-23
Antal sider6
ISSN0009-8981
DOI
StatusUdgivet - feb. 2018

ID: 52794201